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ABSTRACT Addition of sodium bicarbonate (NaHCO3) to standard antimicrobial
susceptibility testing medium reveals certain methicillin-resistant Staphylococcus au-
reus (MRSA) strains to be highly susceptible to -lactams. We investigated the preva-
lence of this phenotype (NaHCO3 responsiveness) to two -lactams among 58 clini-
cal MRSA bloodstream isolates. Of note, 75% and 36% of isolates displayed the
NaHCO3 responsiveness phenotype to cefazolin (CFZ) and oxacillin (OXA), respec-
tively. Neither intrinsic -lactam MICs in standard Mueller-Hinton broth (MHB) nor
population analysis profiles were predictive of this phenotype. Several genotypic
markers (clonal complex 8 [CC8]; agr I and spa t008) were associated with NaHCO3
responsiveness for OXA.
KEYWORDS antimicrobial susceptibility testing, beta-lactams, methicillin-resistant
Staphylococcus aureus, sodium bicarbonate
Staphylococcus aureus is a serious community and nosocomial pathogen and aleading cause of bacteremia, infective endocarditis, and device-related infections (1,
2). Many of these infections are caused by methicillin-resistant S. aureus (MRSA), which
is generally perceived to be “resistant” to those -lactam antibiotic therapies used for
the treatment of methicillin-susceptible S. aureus (MSSA) (3). MRSA exhibits in vitro
resistance to oxacillin (OXA) by standard antimicrobial susceptibility testing (AST),
which has been extrapolated to apply to all other -lactams (excluding ceftaroline and
ceftobiprole) (4). However, as shown recently, in vitro antimicrobial resistance of MRSA
(and selected Gram-negative bacilli) may not always correlate to therapeutic resistance
in vivo (5–8). Thus, efforts have been made to more effectively model the host
environment in newer in vitro AST to improve the predictive power of these assays with
regard to clinical outcomes (6, 7, 9). These modified AST protocols utilize tissue culture
media or media that contain specific ions that a pathogen would consistently encoun-
ter within a host (e.g., sodium bicarbonate [NaHCO3]).
Recently, we identified a novel MRSA AST phenotype, termed “NaHCO3 responsive-
ness,” in which MRSA strains are highly susceptible in vitro to cefazolin (CFZ) and OXA
in a medium supplemented with NaHCO3 (7). Prototype MRSA strains with this in vitro
phenotype were also highly susceptible to these same -lactams in an ex vivo simulated
endocarditis vegetation model as well as in a rabbit model of infective endocarditis (7,
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10). In contrast, in vitro NaHCO3-nonresponsive isolates were also resistant to CFZ and
OXA under these same ex vivo and in vivo conditions.
The aim of this study was to delineate the frequency of the NaHCO3-responsive/
nonresponsive phenotypes in vitro among a larger MRSA strain set. Thus, we analyzed
a collection of 58 MRSA bloodstream isolates for the following to determine potential
predictive markers of NaHCO3 responsiveness: (i) NaHCO3-responsive phenotypes to
CFZ and OXA and (ii) linkage of this phenotype with other known phenotypic and
genotypic markers. We identified a relatively large subset of NaHCO3-responsive strains
to CFZ and/or OXA within this MRSA cohort.
(This study was presented in part at the IDWeek Conference, Washington, DC,
October 2019 [11].)
Frequency of NaHCO3 responsiveness. Among 58 clinical MRSA isolates, 22 were
vancomycin- and daptomycin-susceptible bloodstream isolates obtained from the
Cubist Isolate Collection. The remaining 36 strains (also vancomycin and daptomycin
susceptible) were from bacteremic patients at Duke University Medical Center (kindly
provided by Vance Fowler) (12). Fifty-five of the 58 isolates were -lactamase positive
as determined by nitrocefin disk assay as per manufacturer’s instructions (Becton,
Dickinson).
The NaHCO3-responsive phenotype to CFZ and OXA was defined as4-fold reduc-
tion in MICs in the presence versus absence of 44 mM NaHCO3 by broth microdilution
assay (7). Previously, we determined that this in vitro criterion was a good predictor of
in vivo outcomes in a rabbit model of MRSA infective endocarditis (7). The majority of
strains displayed NaHCO3 responsiveness to at least one of the two -lactams (Fig. 1A;
see also Table S1 in the supplemental material). Thus, 44/58 (76%) and 21/58 (36%)
tested strains displayed reduced MICs to CFZ and OXA, respectively, in the presence
of NaHCO3 (Fig. 1A). Additionally, the majority of such responsive strains displayed
a8-fold reduction in MICs in the presence of NaHCO3 (82% for CFZ and 71% for OXA)
(Fig. 1A).
We identified 20/58 (35%) strains to be coresponsive to both CFZ and OXA, while
13/58 (22%) strains were responsive to neither drug (Fig. 1B). The significance of this
correlation was calculated by the kappa coefficient () for the coresponsive phenotype.
Although the kappa coefficient indicated a positive correlation for this coresponsive-
ness, there were also a significant number of strains with discordant phenotypes
(NaHCO3 responsive to only CFZ or only OXA) in our cohort sample (McNemar’s test;
****, P 0.0001) (Fig. 1B). The majority of coresponsive phenotypes appeared to be
driven by the 20/21 OXA-responsive strains that were also responsive to CFZ. These
data indicate that testing for NaHCO3 responsiveness to OXA is a reasonable proxy for
NaHCO3 responsiveness to CFZ but not vice versa.
FIG 1 Frequency of NaHCO3 responsiveness among 58 clinical MRSA isolates. (A) Frequency of NaHCO3
responsiveness to cefazolin (CFZ) and oxacillin (OXA). Responsiveness is defined as a4-fold reduction
in MIC in the presence of NaHCO3 compared to that of medium lacking NaHCO3. (B) Frequency of
coresponsiveness to CFZ and OXA. Coresponsiveness is defined as a strain that is NaHCO3 responsive to
both CFZ and OXA. Correlated phenotypes are those in which a strain is either responsive to both drugs
(coresponsive) or responsive to neither drug (nonresponsive). Discordant phenotypes are those in which
a strain is responsive to only one drug (either CFZ or OXA). Kappa coefficient of correlation () 0.25,
**, P 0.008.
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Recent interest has focused on the use of the tissue culture medium, RPMI 1640, for
AST as a more host-mimicking milieu, particularly for Gram-negative bacteria (13–15).
In a previous study of five prototype MRSA strains, we determined that AST in RMPI
1640 (containing 25 mM NaHCO3) resulted in a4-fold decrease in MICs to CFZ and
OXA, despite only two of the five becoming susceptible to these same -lactams in
44 mM NaHCO3-Mueller-Hinton broth (MHB) medium. Moreover, only the two NaHCO3-
responsive strains were cleared in vivo from experimental endocarditis target tissues
by these two -lactams (7). To further assess the impact of RPMI medium on MRSA
-lactam MICs in the current cohort, 58/58 (100%) and 50/58 (86%) strains were
rendered highly susceptible to CFZ and OXA, respectively, when tested in RMPI 1640
(see Table S1). Thus, RPMI medium does not appear to be a discriminative candidate as
a host-mimicking medium for new MRSA AST.
Population analysis profiles, time-kill synergy, and intrinsic (baseline) MICs of
NaHCO3-responsive versus nonresponsive strains. Homoresistant MRSA strains are
typically classified as those in which essentially the entire cell population displays the
same level of resistance to an antibiotic of interest by population analysis profile (PAP)
(16). In contrast, in heteroresistant strains, only a relatively small “subpopulation” of
cells within the entire population display high-level resistance. Thus, PAPs were carried
out on two responsive (PB 043-043 and PB 031-038) and two nonresponsive MRSA
strains (C7 and RB 067-227) from our cohort in the presence and absence of NaHCO3
as previously described (7). All four strains exhibited a homoresistant CFZ PAP in
standard Mueller-Hinton agar (MHA). Of note, both responsive strains demonstrated a
significant repression of the overall resistant subpopulation in the presence of NaHCO3
(Fig. 2A). In contrast, neither nonresponsive strain PAP was impacted by growth in
NaHCO3-containing medium (Fig. 2B). As expected, the PAP of an MSSA isolate deter-
mined in medium NaHCO3 was homogenously susceptible to CFZ in both conditions
(Fig. 2C). Upon further PAP testing of the remaining strains within the cohort, a large
proportion of responsive strains had homoresistant PAPs, with only two strains exhib-
iting heteroresistant PAPs (see Table S2 in the supplemental material). Similarly, the
vast majority of nonresponsive strains tested had homoresistant PAPs, but this was not
uniformly found among this group (Table S2). Thus, there was no obvious linkage
between NaHCO3 responsiveness and heteroresistance (7) or NaHCO3 nonresponsive-
ness and homoresistance. These data underscore the notion that NaHCO3 responsive-
ness/nonresponsiveness is not merely a reflection of the proportion of the -lactam-
resistant subpopulations within a given MRSA strain; it is more likely that complex
microbial factors are in-play.
We assessed potential synergistic killing between NaHCO3 plus -lactams in respon-
sive versus nonresponsive strains by time-kill assay (7). Synergy was defined as a 2
log10 CFU/ml difference in counts at 24 h when comparing the -lactam agent alone
versus the combination of -lactam plus NaHCO3. To qualify for synergy, there also had
to be a bactericidal impact of the -lactam plus NaHCO3 combination (i.e., 3 log10
CFU/ml decrease from the 0 h starting inoculum). In two responsive strains, only one
strain (PB 043-043) exhibited both a bactericidal and synergistic impact of CFZ plus
NaHCO3 (Fig. 3A and B). In contrast, neither nonresponsive strain displayed either a
bactericidal or synergistic impact of CFZ or OXA plus NaHCO3 versus medium alone
(Fig. 3C and D).
We assessed whether the NaHCO3-responsive phenotype might be predicted by a
relatively low intrinsic (baseline) MIC to CFZ and OXA in standard MHB (i.e., an MIC
in standard community-associated methicillin-resistant Staphylococcus aureus [CA-
MHB] of 64 g/ml). However, such lower intrinsic MICs were only randomly associ-
ated with NaHCO3 responsiveness for both drugs (Fig. 4A and B).
Taken together, the above data indicate that other intrinsic microbial properties,
rather than the proportion of resistant cells within a population or the magnitude of
that resistance, dictate the net bacteriostatic and/or bactericidal effects of CFZ and OXA
in the presence of NaHCO3.
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Genotypic correlates of NaHCO3 responsivity. We determined potential relation-
ships between several well-characterized genotypic markers in MRSA with the NaHCO3-
responsive phenotype for either -lactam, employing clonal complex (CC) type, agr
type, spa type, and staphylococcal cassette chromosome mec element (SCCmec) type.
The CC, agr, spa, and SCCmec types were determined as previously described (17–20).
There was a broad range of CC types observed in our cohort (see Table S1); however,
only CC types 5 and 8 provided a large enough sample size to make any statistical
inferences. Neither of these two CC types was a statistically better predictor of respon-
siveness to CFZ (see Fig. S1A in the supplemental material). Interestingly, CC8 strains
had a significantly higher proportion of OXA-NaHCO3-responsive strains than CC5
strains (Fig. S1B). Similar to what was observed in the CC type data, neither agr type I
or II strains were a better predictor of responsiveness to CFZ (see Table S1; chi-square
analysis; P 0.9); in contrast, agr type I strains exhibited a significantly higher fre-
quency of OXA NaHCO3 responsiveness than agr type II strains (chi-square analysis; **,
P 0.009). Our cohort consisted of a diverse array of spa types (17 different variants;
see Table S1); however, only spa types t008 and t002 were frequent enough to merit
statistical analysis. As with CC and agr types, neither spa type was significantly linked
FIG 2 Population analysis profiles for NaHCO3-responsive and nonresponsive strains. (A) Population
analysis profiles of CFZ for NaHCO3-responsive strains in the presence and absence of NaHCO3. The area
under the curve (AUC), calculated by linear approximation, was significantly decreased by exposure to
NaHCO3 in both strains as analyzed by Student’s t test (PB 043-043, ***, P 0.001; PB 031-038, ****,
P 0.0001). (B) Population analysis profiles of CFZ for NaHCO3-nonresponsive strains in the presence and
absence of NaHCO3. As analyzed by Student’s t test, there is no significant difference in the AUC for C7
in media  NaHCO3; the AUC of RB 067-227 was significantly increased by exposure to NaHCO3 (*,
P 0.05). (C) Population analysis profiles of CFZ for the methicillin-susceptible S. aureus (MSSA) strain
ATCC 25923.
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to CFZ responsiveness, while spa type t008 was significantly linked to OXA responsive-
ness (Table S1). Although our statistical analyses indicate that certain genotypic mark-
ers are more commonly associated with OXA-NaHCO3 responsiveness, our sample size
is too small to draw any definitive predictive conclusions.
The majority of strains (59%) were either SCCmec type IV (59%) or SCCmec type II
(38%) (Table S1), with no significant associations with NaHCO3 responsivity for CFZ
or OXA.
It appears that the NaHCO3 responsiveness phenotype and sensitization of MRSA to
two prototype standard-of-care -lactams is relatively frequent, especially for CFZ. This
phenotype does not appear to be related to the size of the resistant subpopulation or
the intrinsic MIC of responsive strains. Although our data suggest that certain genotypic
FIG 3 Time kill curves for NaHCO3-responsive and nonresponsive strains. (A) PB 043-043 (squares). (B) PB
031-038 (circles). (C) C7 (diamonds). (D) RB 067-227 (triangles). Closed symbols represent growth in
CA-MHB 100 mM Tris, open symbols represent growth in CA-MHB 100 mM Tris 44 mM NaHCO3, solid
lines represent no drug control, dashed lines represent exposure to CFZ, and dotted lines represents
exposure to OXA. Drug concentrations for PB 043-043 were 16 g/ml for CFZ and 32 g/ml for OXA; drug
concentrations for all other strains were 64 g/ml for both CFZ and OXA.
FIG 4 Relationship between intrinsic MIC and responsiveness for CFZ and OXA. (A) CFZ. (B) OXA. Both
graphs show low intrinsic MIC/responsive (black), high intrinsic MIC/nonresponsive (white), low intrinsic
MIC/nonresponsive (light gray), and high intrinsic MIC/responsive (dark gray). Relationship between
intrinsic MIC and responsiveness for CFZ is random ( 0.01; 95% confidence interval (CI)  0.24 to
0.27; Kappa coefficient and McNemar’s test, P 0.05). Relationship between intrinsic MIC and respon-
siveness to OXA is also random with significant discordance ( 0.02; 95% CI  0.21 to 0.25; Kappa
coefficient, P 0.05; McNemar’s test *, P 0.01).
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markers may be linked to OXA responsiveness, a larger cohort is needed to verify this
observation.
Interestingly, a recent study by Quach et al. identified a subset of closely related
MRSA strains, falling within the multilocus sequence type ST8 grouping (a lineage
encompassed within CC8), that display unexpected high rates of lysis in the presence
of -lactams (21). This may point to one potential mechanism contributing to NaHCO3
responsiveness, i.e., NaHCO3-enhanced, -lactam-mediated lysis. We are currently ex-
amining this phenotype among the 58 MRSA isolates described in the current study.
In summary, if the association of in vitro NaHCO3 responsiveness and -lactam
sensitization can be further validated experimentally in vivo using larger MRSA cohorts,
a well-designed clinical trial to verify this relationship may well be justified.
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